2mg CS0159: Clinical Trials

1 trial of 2mg CS0159, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 active not recruiting. 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 21Active not recruiting 1

Follow 2mg CS0159: new trials by email Literature Review of 2mg CS0159 trials Research Report on 2mg CS0159

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
CS0159 in Chinese Patients With PBC (Primary Biliary Cholangitis)
2mg CS0159, Placebo - Primary Biliary Cholangitis (PBC)
Phase 2Active not recruitingCascade Pharmaceuticals, Inc752023-08-072026-03-13

Conditions studied

Liver Cirrhosis, Biliary (1)

Sponsors

Cascade Pharmaceuticals, Inc (1)

Countries

China (1)

Top investigators

Rong Deng (1)